2018 AANS Annual Scientific Meeting-Scientific Session IV: Pediatrics, Question and Answer Session IV

Scientific Session IV: Pediatrics, Question and Answer Session IV

Video Transcription

Video Summary

In this video, the presenter discusses the use of tranexamic acid (TXA) in reducing blood transfusions post-surgery. The presenter mentions that in two studies, TXA acted as a clot stabilizer, resulting in no post-operative blood transfusions, unlike the placebo group. The study showed that patients who received TXA were exposed to fewer units of blood compared to those who received a placebo. The presenter also mentions that some centers have achieved no transfusions with the use of TXA. TXA is commonly used in craniofacial cases and brain tumor cases that are expected to be bloody. It has become standard of care in cardiac and spine cases due to its safety and effectiveness. The presenter suggests that surgical and anesthetic techniques play a significant role in reducing blood loss.

Asset Caption

Scientific Session IV: Pediatrics, Question and Answer Session IV

Keywords

tranexamic acid

blood transfusions

clot stabilizer

post-operative

placebo group